SIVEXTRO 200 mg/4mL
tedizolid phosphate · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Merck Sharp & Dohme LLC
SIVEXTRO is a injection, powder, lyophilized, for solution containing tedizolid phosphate at 200 mg/4mL, taken intravenous. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- SIVEXTRO
- Generic Name
- tedizolid phosphate
- NDC Code (Product)
67919-040- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 200 mg/4mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA205436
- Marketing Start
- 06/20/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is SIVEXTRO used for?
SIVEXTRO contains tedizolid phosphate. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is SIVEXTRO a controlled substance?
SIVEXTRO is not classified as a controlled substance by the DEA.
What is the generic name for SIVEXTRO?
The generic name for SIVEXTRO is tedizolid phosphate. There are no other listed brand versions of tedizolid phosphate.
What is the NDC code for SIVEXTRO 200 mg/4mL?
The NDC (National Drug Code) for SIVEXTRO 200 mg/4mL is 67919-040, listed by Merck Sharp & Dohme LLC.
Other SIVEXTRO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)